⌘K
Loading ticker…
As of 2026-08-21, Tango Therapeutics, Inc. (TNGX) has a 3-month relative strength percentile of 67 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 82. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.9%, relative volume 1.08×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TNGX is held by 21 ETFs as of May 2026. Top owner: VTWO at 0.07% weight, $13M notional. Top 3 carry $28M.
Held by 48 ETFs · $301M across latest filings · largest weight 2.85% (PTH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.07% | $13M | +0.03 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.05% | $10M | +0.02 pp |
| DWAS | 1.31% | $5M | new |
| VFMO | 0.18% | $3M | +0.05 pp |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.15% |
| $2M |
| +0.07 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| ONEQ | 0.01% | $792K | — |
| GSSC | 0.07% | $717K | new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $209K | — |
Showing 10 of 21 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TNGX Jan avg: 9.30% median: 7.56% win: 50% σ: 18.79% n: 4 2022-04-12 → 2026-07-31 | TNGX Feb avg: -15.15% median: -13.02% win: 0% σ: 12.77% n: 4 2022-04-12 → 2026-07-31 | TNGX Mar avg: 0.21% median: -26.57% win: 25% σ: 58.51% n: 4 2022-04-12 → 2026-07-31 | TNGX Apr avg: -2.16% median: -0.14% win: 40% σ: 7.06% n: 5 2022-04-12 → 2026-07-31 | TNGX May avg: 3.86% median: -9.10% win: 40% σ: 30.98% n: 5 2022-04-12 → 2026-07-31 | TNGX Jun avg: 37.50% median: 23.99% win: 80% σ: 59.08% n: 5 2022-04-12 → 2026-07-31 | TNGX Jul avg: 2.36% median: 1.81% win: 60% σ: 13.98% n: 5 2022-04-12 → 2026-07-31 | TNGX Aug avg: 30.86% median: 15.60% win: 100% σ: 41.57% n: 4 2022-04-12 → 2026-07-31 (current) | TNGX Sep avg: 13.02% median: 6.74% win: 50% σ: 47.31% n: 4 2022-04-12 → 2026-07-31 | TNGX Oct avg: 15.96% median: -14.43% win: 25% σ: 71.67% n: 4 2022-04-12 → 2026-07-31 | TNGX Nov avg: -2.27% median: -8.06% win: 25% σ: 26.22% n: 4 2022-04-12 → 2026-07-31 | TNGX Dec avg: -3.39% median: -11.13% win: 25% σ: 23.81% n: 4 2022-04-12 → 2026-07-31 |